Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

Item

http://www.wikidata.org/entity/Q26738346

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@ast

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@en

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@nl

type

Item

label

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@ast

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@en

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@nl

prefLabel

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@ast

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@en

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@nl

P1476

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

@en

P2093

Anastasia Constantinidou

http://www.w3.org/2001/XMLSchema#string

Ingrid M E Desar

http://www.w3.org/2001/XMLSchema#string

Suzanne E J Kaal

http://www.w3.org/2001/XMLSchema#string

Winette T A van der Graaf

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.

P304

95-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4039598

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/CMAR.S86746

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robin L Jones

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27574465

http://www.w3.org/2001/XMLSchema#string

P932

4993282

http://www.w3.org/2001/XMLSchema#string